Clinical Trials in Georgia

Showing 6601-6620 of 19,050 trials

MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005)

NCT04308304

The study investigated the effects on safety and pharmacokinetics (PK) of MK-1942 and donepezil when co-administered to participants with Alzheimer's Disease with mild-to-moderate cognitive impairment stably treated with donepezil. The objectives of this study were to determine if the combination of MK-1942 with donepezil increases the incidence or severity of adverse events (AEs) previously reported for these agents alone, or results in unanticipated AEs in the patient population targeted for MK-1942 treatment. In addition, changes in the PK parameters of either MK-1942 or donepezil as a result of co-administration were assessed.

Alzheimer's Disease

Merck Sharp & Dohme LLC27 participantsStarted Feb 2021

Rogers, Arkansas, United States • Hallandale, Florida, United States • Decatur, Georgia, United States +1 more locations

TERMINATEDPhase 1144 miles

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

NCT05251727

To evaluate the safety and tolerability of ART-123 in patients with metastatic colorectal cancer who receive oxaliplatin-containing chemotherapy and bevacizumab

Chemotherapy-induced Peripheral Neuropathy

Veloxis Pharmaceuticals77 participantsStarted Mar 2022

Beverly Hills, California, United States • Los Angeles, California, United States • Norwich, Connecticut, United States +29 more locations

MK-1942/Donepezil Interactions in Participants With Alzheimer's Disease (MK-1942-005)

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients

Find Trials by Condition in Georgia

Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)

Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis

Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML

Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

Physiologic Pacing Registry

Situation Awareness Incorporating Multidisciplinary Teams Reduce Arrests In the Pediatric ICU

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial)

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

CardioFocus HeartLight Post-Approval Study

A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women

Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions

ROX Index for the Timing of Intubation in Nasal High Flow

Cefadroxil 500 mg Capsules Under Fasting Conditions

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping